GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (STU:OLY1) » Definitions » Cyclically Adjusted Revenue per Share

Olympus (STU:OLY1) Cyclically Adjusted Revenue per Share : €3.85 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Olympus Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Olympus's adjusted revenue per share for the three months ended in Mar. 2024 was €1.363. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €3.85 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Olympus's average Cyclically Adjusted Revenue Growth Rate was 5.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Olympus was 1.70% per year. The lowest was -4.20% per year. And the median was -2.85% per year.

As of today (2024-05-24), Olympus's current stock price is €14.865. Olympus's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €3.85. Olympus's Cyclically Adjusted PS Ratio of today is 3.86.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Olympus was 5.19. The lowest was 1.12. And the median was 2.65.


Olympus Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Olympus's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Cyclically Adjusted Revenue per Share Chart

Olympus Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.27 4.69 4.35 4.20 3.85

Olympus Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.20 3.91 3.97 4.04 3.85

Competitive Comparison of Olympus's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Olympus's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Olympus's Cyclically Adjusted PS Ratio falls into.



Olympus Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Olympus's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.363/107.2000*107.2000
=1.363

Current CPI (Mar. 2024) = 107.2000.

Olympus Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.880 98.000 0.963
201409 0.992 98.500 1.080
201412 0.968 97.900 1.060
201503 1.203 97.900 1.317
201506 0.986 98.400 1.074
201509 1.127 98.500 1.227
201512 1.085 98.100 1.186
201603 1.231 97.900 1.348
201606 1.040 98.100 1.136
201609 1.151 98.000 1.259
201612 1.092 98.400 1.190
201703 1.262 98.100 1.379
201706 1.007 98.500 1.096
201709 1.093 98.800 1.186
201712 1.107 99.400 1.194
201803 1.200 99.200 1.297
201806 1.028 99.200 1.111
201809 1.126 99.900 1.208
201812 1.142 99.700 1.228
201903 1.240 99.700 1.333
201906 1.090 99.800 1.171
201909 1.264 100.100 1.354
201912 1.237 100.500 1.319
202003 1.267 100.300 1.354
202006 0.877 99.900 0.941
202009 1.124 99.900 1.206
202012 1.213 99.300 1.310
202103 1.303 99.900 1.398
202106 1.122 99.500 1.209
202109 1.159 100.100 1.241
202112 1.131 100.100 1.211
202203 1.218 101.100 1.291
202206 1.066 101.800 1.123
202209 1.243 103.100 1.292
202212 1.237 104.100 1.274
202303 1.338 104.400 1.374
202306 1.080 105.200 1.101
202309 1.174 106.200 1.185
202312 1.272 106.800 1.277
202403 1.363 107.200 1.363

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Olympus  (STU:OLY1) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Olympus's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=14.865/3.85
=3.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Olympus was 5.19. The lowest was 1.12. And the median was 2.65.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Olympus Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Olympus's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus (STU:OLY1) Business Description

Industry
Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (STU:OLY1) Headlines

No Headlines